Alexandra Franiek1, Atul Sharma2, Vedran Cockovski3, David S Wishart4, Michael Zappitelli5, Tom D Blydt-Hansen6. 1. College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, Scotland. 2. Department of Pediatrics and Child Health, Children's Hospital at Health Sciences Center, University of Manitoba, Winnipeg, MB, Canada. 3. SickKids Research Institute, University of Toronto, Toronto, ON, Canada. 4. The Metabolomics Innovation Center, University of Alberta, Edmonton, AB, Canada. 5. Department of Pediatrics, Division of Nephrology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Québec, Canada. 6. Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada. Tom.BlydtHansen@cw.bc.ca.
Abstract
BACKGROUND: Acute kidney injury (AKI) is characterized by an abrupt decline in glomerular filtration rate (GFR). We sought to identify separate early urinary metabolomic signatures at AKI onset (with-AKI) and prior to onset of functional impairment (pre-AKI). METHODS: Pre-AKI (n=15), AKI (n=22), and respective controls (n=30) from two prospective PICU cohort studies provided urine samples which were analyzed by GC-MS and DI-MS mass spectrometry (193 metabolites). The cohort (n=58) was 8.7±6.4 years old and 66% male. AKI patients had longer PICU stays, higher PRISM scores, vasopressors requirement, and respiratory diagnosis and less commonly had trauma or post-operative diagnosis. Urine was collected within 2-3 days after admission and daily until day 5 or 14. RESULTS: The metabolite classifiers for pre-AKI samples (1.5±1.1 days prior to AKI onset) had a cross-validated area under receiver operator curve (AUC)=0.93 (95%CI 0.85-1.0); with-AKI samples had an AUC=0.94 (95%CI 0.87-1.0). A parsimonious pre-AKI classifier with 13 metabolites was similarly robust (AUC=0.96, 95%CI 0.89-1.0). Both classifiers were similar and showed modest correlation of high-ranking metabolites (tau=0.47, p<0.001). CONCLUSIONS: This exploratory study demonstrates the potential of a urine metabolite classifier to detect AKI-risk in pediatric populations earlier than the current standard of diagnosis with the need for external validation. A higher resolution version of the Graphical abstract is available as Supplementary information with inner reference to ESM for GA.
BACKGROUND: Acute kidney injury (AKI) is characterized by an abrupt decline in glomerular filtration rate (GFR). We sought to identify separate early urinary metabolomic signatures at AKI onset (with-AKI) and prior to onset of functional impairment (pre-AKI). METHODS: Pre-AKI (n=15), AKI (n=22), and respective controls (n=30) from two prospective PICU cohort studies provided urine samples which were analyzed by GC-MS and DI-MS mass spectrometry (193 metabolites). The cohort (n=58) was 8.7±6.4 years old and 66% male. AKI patients had longer PICU stays, higher PRISM scores, vasopressors requirement, and respiratory diagnosis and less commonly had trauma or post-operative diagnosis. Urine was collected within 2-3 days after admission and daily until day 5 or 14. RESULTS: The metabolite classifiers for pre-AKI samples (1.5±1.1 days prior to AKI onset) had a cross-validated area under receiver operator curve (AUC)=0.93 (95%CI 0.85-1.0); with-AKI samples had an AUC=0.94 (95%CI 0.87-1.0). A parsimonious pre-AKI classifier with 13 metabolites was similarly robust (AUC=0.96, 95%CI 0.89-1.0). Both classifiers were similar and showed modest correlation of high-ranking metabolites (tau=0.47, p<0.001). CONCLUSIONS: This exploratory study demonstrates the potential of a urine metabolite classifier to detect AKI-risk in pediatric populations earlier than the current standard of diagnosis with the need for external validation. A higher resolution version of the Graphical abstract is available as Supplementary information with inner reference to ESM for GA.
Authors: David Marx; Jochen Metzger; Martin Pejchinovski; Ryan Bruce Gil; Maria Frantzi; Agnieszka Latosinska; Iwona Belczacka; Silke Sophie Heinzmann; Holger Husi; Jerome Zoidakis; Matthias Klingele; Stefan Herget-Rosenthal Journal: Semin Nephrol Date: 2018-01 Impact factor: 5.299
Authors: Tom D Blydt-Hansen; Atul Sharma; Ian W Gibson; David S Wishart; Rupasri Mandal; Julie Ho; Peter Nickerson; David Rush Journal: Transplantation Date: 2017-10 Impact factor: 4.939
Authors: Jennifer Palermo; Allison B Dart; Alanna De Mello; Prasad Devarajan; Ronald Gottesman; Gonzalo Garcia Guerra; Greg Hansen; Ari R Joffe; Cherry Mammen; Nick Majesic; Catherine Morgan; Peter Skippen; Michael Pizzi; Ana Palijan; Michael Zappitelli Journal: Pediatr Crit Care Med Date: 2017-06 Impact factor: 3.624
Authors: A Akcan-Arikan; M Zappitelli; L L Loftis; K K Washburn; L S Jefferson; S L Goldstein Journal: Kidney Int Date: 2007-03-28 Impact factor: 10.612
Authors: Marta Martin-Lorenzo; Laura Gonzalez-Calero; Angeles Ramos-Barron; Maria D Sanchez-Niño; Carlos Gomez-Alamillo; Juan Manuel García-Segura; Alberto Ortiz; Manuel Arias; Fernando Vivanco; Gloria Alvarez-Llamas Journal: J Mol Med (Berl) Date: 2017-10-04 Impact factor: 4.599
Authors: Kelly Benisty; Catherine Morgan; Erin Hessey; Louis Huynh; Ari R Joffe; Daniel Garros; Adrian Dancea; Reginald Sauve; Ana Palijan; Michael Pizzi; Sudeshna Bhattacharya; Julie Ann Doucet; Vedran Cockovski; Ronald G Gottesman; Stuart L Goldstein; Michael Zappitelli Journal: Pediatr Res Date: 2020-01-02 Impact factor: 3.756